_version_ 1783613273141149696
author Lim, Jing Quan
Huang, Dachuan
Tang, Tiffany
Tan, Daryl
Laurensia, Yurike
Peng, Rou-Jun
Wong, Esther Kam Yin
Cheah, Daryl Ming Zhe
Chia, Burton Kuan Hui
Iqbal, Jabed
Grigoropoulos, Nicholas Francis
Nairismägi, Maarja-Liisa
Ng, Cedric Chuan Young
Rajasegaran, Vikneswari
Hong, Huangming
Kim, Seok Jin
Cho, Junhun
Tse, Eric
Mow, Benjamin
Cai, Qi-Chun
Poon, Li-Mei
Cai, Qing-qing
Tan, Jing
Chan, Jason Yongsheng
Lim, Johnathan Xiande
Goh, Yeow Tee
Phipps, Colin
Rötzschke, Olaf
Cheng, Chee Leong
Ha, Jeslin Chian Hung
Khoo, Lay Poh
Loh, Yvonne Su Ming
Au-Yeung, Rex
Chan, Thomas Sau-Yan
Kwong, Yok-Lam
Hwang, William
Kim, Won Seog
Bei, Jin-Xin
Lin, Tongyu
Ong, Choon Kiat
Lim, Soon Thye
author_facet Lim, Jing Quan
Huang, Dachuan
Tang, Tiffany
Tan, Daryl
Laurensia, Yurike
Peng, Rou-Jun
Wong, Esther Kam Yin
Cheah, Daryl Ming Zhe
Chia, Burton Kuan Hui
Iqbal, Jabed
Grigoropoulos, Nicholas Francis
Nairismägi, Maarja-Liisa
Ng, Cedric Chuan Young
Rajasegaran, Vikneswari
Hong, Huangming
Kim, Seok Jin
Cho, Junhun
Tse, Eric
Mow, Benjamin
Cai, Qi-Chun
Poon, Li-Mei
Cai, Qing-qing
Tan, Jing
Chan, Jason Yongsheng
Lim, Johnathan Xiande
Goh, Yeow Tee
Phipps, Colin
Rötzschke, Olaf
Cheng, Chee Leong
Ha, Jeslin Chian Hung
Khoo, Lay Poh
Loh, Yvonne Su Ming
Au-Yeung, Rex
Chan, Thomas Sau-Yan
Kwong, Yok-Lam
Hwang, William
Kim, Won Seog
Bei, Jin-Xin
Lin, Tongyu
Ong, Choon Kiat
Lim, Soon Thye
author_sort Lim, Jing Quan
collection PubMed
description
format Online
Article
Text
id pubmed-7685978
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-76859782020-12-03 Whole-genome sequencing identifies responders to Pembrolizumab in relapse/refractory natural-killer/T cell lymphoma Lim, Jing Quan Huang, Dachuan Tang, Tiffany Tan, Daryl Laurensia, Yurike Peng, Rou-Jun Wong, Esther Kam Yin Cheah, Daryl Ming Zhe Chia, Burton Kuan Hui Iqbal, Jabed Grigoropoulos, Nicholas Francis Nairismägi, Maarja-Liisa Ng, Cedric Chuan Young Rajasegaran, Vikneswari Hong, Huangming Kim, Seok Jin Cho, Junhun Tse, Eric Mow, Benjamin Cai, Qi-Chun Poon, Li-Mei Cai, Qing-qing Tan, Jing Chan, Jason Yongsheng Lim, Johnathan Xiande Goh, Yeow Tee Phipps, Colin Rötzschke, Olaf Cheng, Chee Leong Ha, Jeslin Chian Hung Khoo, Lay Poh Loh, Yvonne Su Ming Au-Yeung, Rex Chan, Thomas Sau-Yan Kwong, Yok-Lam Hwang, William Kim, Won Seog Bei, Jin-Xin Lin, Tongyu Ong, Choon Kiat Lim, Soon Thye Leukemia Letter Nature Publishing Group UK 2020-08-05 2020 /pmc/articles/PMC7685978/ /pubmed/32753688 http://dx.doi.org/10.1038/s41375-020-1000-0 Text en © The Author(s) 2020, corrected publication 2021 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Letter
Lim, Jing Quan
Huang, Dachuan
Tang, Tiffany
Tan, Daryl
Laurensia, Yurike
Peng, Rou-Jun
Wong, Esther Kam Yin
Cheah, Daryl Ming Zhe
Chia, Burton Kuan Hui
Iqbal, Jabed
Grigoropoulos, Nicholas Francis
Nairismägi, Maarja-Liisa
Ng, Cedric Chuan Young
Rajasegaran, Vikneswari
Hong, Huangming
Kim, Seok Jin
Cho, Junhun
Tse, Eric
Mow, Benjamin
Cai, Qi-Chun
Poon, Li-Mei
Cai, Qing-qing
Tan, Jing
Chan, Jason Yongsheng
Lim, Johnathan Xiande
Goh, Yeow Tee
Phipps, Colin
Rötzschke, Olaf
Cheng, Chee Leong
Ha, Jeslin Chian Hung
Khoo, Lay Poh
Loh, Yvonne Su Ming
Au-Yeung, Rex
Chan, Thomas Sau-Yan
Kwong, Yok-Lam
Hwang, William
Kim, Won Seog
Bei, Jin-Xin
Lin, Tongyu
Ong, Choon Kiat
Lim, Soon Thye
Whole-genome sequencing identifies responders to Pembrolizumab in relapse/refractory natural-killer/T cell lymphoma
title Whole-genome sequencing identifies responders to Pembrolizumab in relapse/refractory natural-killer/T cell lymphoma
title_full Whole-genome sequencing identifies responders to Pembrolizumab in relapse/refractory natural-killer/T cell lymphoma
title_fullStr Whole-genome sequencing identifies responders to Pembrolizumab in relapse/refractory natural-killer/T cell lymphoma
title_full_unstemmed Whole-genome sequencing identifies responders to Pembrolizumab in relapse/refractory natural-killer/T cell lymphoma
title_short Whole-genome sequencing identifies responders to Pembrolizumab in relapse/refractory natural-killer/T cell lymphoma
title_sort whole-genome sequencing identifies responders to pembrolizumab in relapse/refractory natural-killer/t cell lymphoma
topic Letter
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7685978/
https://www.ncbi.nlm.nih.gov/pubmed/32753688
http://dx.doi.org/10.1038/s41375-020-1000-0
work_keys_str_mv AT limjingquan wholegenomesequencingidentifiesresponderstopembrolizumabinrelapserefractorynaturalkillertcelllymphoma
AT huangdachuan wholegenomesequencingidentifiesresponderstopembrolizumabinrelapserefractorynaturalkillertcelllymphoma
AT tangtiffany wholegenomesequencingidentifiesresponderstopembrolizumabinrelapserefractorynaturalkillertcelllymphoma
AT tandaryl wholegenomesequencingidentifiesresponderstopembrolizumabinrelapserefractorynaturalkillertcelllymphoma
AT laurensiayurike wholegenomesequencingidentifiesresponderstopembrolizumabinrelapserefractorynaturalkillertcelllymphoma
AT pengroujun wholegenomesequencingidentifiesresponderstopembrolizumabinrelapserefractorynaturalkillertcelllymphoma
AT wongestherkamyin wholegenomesequencingidentifiesresponderstopembrolizumabinrelapserefractorynaturalkillertcelllymphoma
AT cheahdarylmingzhe wholegenomesequencingidentifiesresponderstopembrolizumabinrelapserefractorynaturalkillertcelllymphoma
AT chiaburtonkuanhui wholegenomesequencingidentifiesresponderstopembrolizumabinrelapserefractorynaturalkillertcelllymphoma
AT iqbaljabed wholegenomesequencingidentifiesresponderstopembrolizumabinrelapserefractorynaturalkillertcelllymphoma
AT grigoropoulosnicholasfrancis wholegenomesequencingidentifiesresponderstopembrolizumabinrelapserefractorynaturalkillertcelllymphoma
AT nairismagimaarjaliisa wholegenomesequencingidentifiesresponderstopembrolizumabinrelapserefractorynaturalkillertcelllymphoma
AT ngcedricchuanyoung wholegenomesequencingidentifiesresponderstopembrolizumabinrelapserefractorynaturalkillertcelllymphoma
AT rajasegaranvikneswari wholegenomesequencingidentifiesresponderstopembrolizumabinrelapserefractorynaturalkillertcelllymphoma
AT honghuangming wholegenomesequencingidentifiesresponderstopembrolizumabinrelapserefractorynaturalkillertcelllymphoma
AT kimseokjin wholegenomesequencingidentifiesresponderstopembrolizumabinrelapserefractorynaturalkillertcelllymphoma
AT chojunhun wholegenomesequencingidentifiesresponderstopembrolizumabinrelapserefractorynaturalkillertcelllymphoma
AT tseeric wholegenomesequencingidentifiesresponderstopembrolizumabinrelapserefractorynaturalkillertcelllymphoma
AT mowbenjamin wholegenomesequencingidentifiesresponderstopembrolizumabinrelapserefractorynaturalkillertcelllymphoma
AT caiqichun wholegenomesequencingidentifiesresponderstopembrolizumabinrelapserefractorynaturalkillertcelllymphoma
AT poonlimei wholegenomesequencingidentifiesresponderstopembrolizumabinrelapserefractorynaturalkillertcelllymphoma
AT caiqingqing wholegenomesequencingidentifiesresponderstopembrolizumabinrelapserefractorynaturalkillertcelllymphoma
AT tanjing wholegenomesequencingidentifiesresponderstopembrolizumabinrelapserefractorynaturalkillertcelllymphoma
AT chanjasonyongsheng wholegenomesequencingidentifiesresponderstopembrolizumabinrelapserefractorynaturalkillertcelllymphoma
AT limjohnathanxiande wholegenomesequencingidentifiesresponderstopembrolizumabinrelapserefractorynaturalkillertcelllymphoma
AT gohyeowtee wholegenomesequencingidentifiesresponderstopembrolizumabinrelapserefractorynaturalkillertcelllymphoma
AT phippscolin wholegenomesequencingidentifiesresponderstopembrolizumabinrelapserefractorynaturalkillertcelllymphoma
AT rotzschkeolaf wholegenomesequencingidentifiesresponderstopembrolizumabinrelapserefractorynaturalkillertcelllymphoma
AT chengcheeleong wholegenomesequencingidentifiesresponderstopembrolizumabinrelapserefractorynaturalkillertcelllymphoma
AT hajeslinchianhung wholegenomesequencingidentifiesresponderstopembrolizumabinrelapserefractorynaturalkillertcelllymphoma
AT khoolaypoh wholegenomesequencingidentifiesresponderstopembrolizumabinrelapserefractorynaturalkillertcelllymphoma
AT lohyvonnesuming wholegenomesequencingidentifiesresponderstopembrolizumabinrelapserefractorynaturalkillertcelllymphoma
AT auyeungrex wholegenomesequencingidentifiesresponderstopembrolizumabinrelapserefractorynaturalkillertcelllymphoma
AT chanthomassauyan wholegenomesequencingidentifiesresponderstopembrolizumabinrelapserefractorynaturalkillertcelllymphoma
AT kwongyoklam wholegenomesequencingidentifiesresponderstopembrolizumabinrelapserefractorynaturalkillertcelllymphoma
AT hwangwilliam wholegenomesequencingidentifiesresponderstopembrolizumabinrelapserefractorynaturalkillertcelllymphoma
AT kimwonseog wholegenomesequencingidentifiesresponderstopembrolizumabinrelapserefractorynaturalkillertcelllymphoma
AT beijinxin wholegenomesequencingidentifiesresponderstopembrolizumabinrelapserefractorynaturalkillertcelllymphoma
AT lintongyu wholegenomesequencingidentifiesresponderstopembrolizumabinrelapserefractorynaturalkillertcelllymphoma
AT ongchoonkiat wholegenomesequencingidentifiesresponderstopembrolizumabinrelapserefractorynaturalkillertcelllymphoma
AT limsoonthye wholegenomesequencingidentifiesresponderstopembrolizumabinrelapserefractorynaturalkillertcelllymphoma